tizanidine
- Product NDC
- 71610-355
- 11-digit product format
- 716100355
- Labeler code
- 71610
- Product ID
- 71610-355_9daf813b-8fd4-4f12-96a5-d57049869e5c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2004-01-16
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| B53E3NMY5C | TIZANIDINE HYDROCHLORIDE | 64461-82-1 | TIZANIDINE HYDROCHLORIDE |
| 6AI06C00GW | TIZANIDINE | 51322-75-9 | tizanidine |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-355-16 | 71610035516 | 6000 TABLET in 1 BOTTLE (71610-355-16) | 6000 tablet | 2020-08-24 | 0000-00-00 | No | No | Current |
| 71610-355-30 | 71610035530 | 30 TABLET in 1 BOTTLE (71610-355-30) | 30 tablet | 2019-11-18 | 0000-00-00 | No | No | Current |
| 71610-355-53 | 71610035553 | 60 TABLET in 1 BOTTLE (71610-355-53) | 60 tablet | 2019-10-25 | 0000-00-00 | No | No | Current |
| 71610-355-60 | 71610035560 | 90 TABLET in 1 BOTTLE (71610-355-60) | 90 tablet | 2019-10-25 | 0000-00-00 | No | No | Current |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| tizanidine | Aphena Pharma Solutions - Tennessee, LLC | 2020-09-02 | HUMAN PRESCRIPTION DRUG LABEL | 2 |